These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 12780749

  • 1. Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status.
    Scillitani A, Battista C, Chiodini I, Carnevale V, Fusilli S, Ciccarelli E, Terzolo M, Oppizzi G, Arosio M, Gasperi M, Arnaldi G, Colao A, Baldelli R, Ghiggi MR, Gaia D, Di Somma C, Trischitta V, Liuzzi A.
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):725-31. PubMed ID: 12780749
    [Abstract] [Full Text] [Related]

  • 2. Gonadal status is an important determinant of bone density in acromegaly.
    Lesse GP, Fraser WD, Farquharson R, Hipkin L, Vora JP.
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):59-65. PubMed ID: 9509069
    [Abstract] [Full Text] [Related]

  • 3. Spinal volumetric trabecular bone mass in acromegalic patients: a longitudinal study.
    Battista C, Chiodini I, Muscarella S, Guglielmi G, Mascia ML, Carnevale V, Scillitani A.
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):378-82. PubMed ID: 18616713
    [Abstract] [Full Text] [Related]

  • 4. In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender.
    Zgliczynski W, Kochman M, Misiorowski W, Zdunowski P.
    Neuro Endocrinol Lett; 2007 Oct; 28(5):621-8. PubMed ID: 17984937
    [Abstract] [Full Text] [Related]

  • 5. Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function.
    Bolanowski M, Daroszewski J, Medraś M, Zadrozna-Sliwka B.
    J Bone Miner Metab; 2006 Oct; 24(1):72-8. PubMed ID: 16369902
    [Abstract] [Full Text] [Related]

  • 6. Effects of GH-IGF-I excess and gonadal status on bone mineral density and body composition in patients with acromegaly.
    Madeira M, Neto LV, de Lima GA, Moreira RO, de Mendonça LM, Gadelha MR, Farias ML.
    Osteoporos Int; 2010 Dec; 21(12):2019-25. PubMed ID: 20306022
    [Abstract] [Full Text] [Related]

  • 7. Bone mineral density of the axial skeleton in acromegaly.
    Ho PJ, Fig LM, Barkan AL, Shapiro B.
    J Nucl Med; 1992 Sep; 33(9):1608-12. PubMed ID: 1517833
    [Abstract] [Full Text] [Related]

  • 8. Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine.
    Kayath MJ, Vieira JG.
    Osteoporos Int; 1997 Sep; 7(3):226-30. PubMed ID: 9205635
    [Abstract] [Full Text] [Related]

  • 9. Trabecular bone score as a skeletal fragility index in acromegaly patients.
    Hong AR, Kim JH, Kim SW, Kim SY, Shin CS.
    Osteoporos Int; 2016 Mar; 27(3):1123-1129. PubMed ID: 26446771
    [Abstract] [Full Text] [Related]

  • 10. Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism.
    Diamond T, Nery L, Posen S.
    Ann Intern Med; 1989 Oct 01; 111(7):567-73. PubMed ID: 2774387
    [Abstract] [Full Text] [Related]

  • 11. Long-term maintenance of the anabolic effects of GH on the skeleton in successfully treated patients with acromegaly.
    Biermasz NR, Hamdy NA, Pereira AM, Romijn JA, Roelfsema F.
    Eur J Endocrinol; 2005 Jan 01; 152(1):53-60. PubMed ID: 15762187
    [Abstract] [Full Text] [Related]

  • 12. Factors associated with bone metabolism in acromegalic patients: hypogonadism and female gender.
    Tütüncü NB, Erbaş T.
    Exp Clin Endocrinol Diabetes; 2004 Jun 01; 112(6):328-32. PubMed ID: 15216451
    [Abstract] [Full Text] [Related]

  • 13. Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients.
    Scillitani A, Chiodini I, Carnevale V, Giannatempo GM, Frusciante V, Villella M, Pileri M, Guglielmi G, Di Giorgio A, Modoni S, Fusilli S, Di Cerbo A, Liuzzi A.
    J Bone Miner Res; 1997 Oct 01; 12(10):1729-36. PubMed ID: 9333135
    [Abstract] [Full Text] [Related]

  • 14. Serum GH and IGF-I are significant determinants of bone turnover but not bone mineral density in active acromegaly: a prospective study of more than 70 consecutive patients.
    Ueland T, Fougner SL, Godang K, Schreiner T, Bollerslev J.
    Eur J Endocrinol; 2006 Nov 01; 155(5):709-15. PubMed ID: 17062887
    [Abstract] [Full Text] [Related]

  • 15. Effect of gender and gonadal status on the long-term response to somatostatin analogue treatment in acromegaly.
    Colao A, Pivonello R, Cappabianca P, Briganti F, Tortora F, Auriemma RS, De Martino MC, Marzullo P, Lombardi G.
    Clin Endocrinol (Oxf); 2005 Sep 01; 63(3):342-9. PubMed ID: 16117824
    [Abstract] [Full Text] [Related]

  • 16. Bone metabolism and body composition in Japanese patients with active acromegaly.
    Kaji H, Sugimoto T, Nakaoka D, Okimura Y, Kaji H, Abe H, Chihara K.
    Clin Endocrinol (Oxf); 2001 Aug 01; 55(2):175-81. PubMed ID: 11531923
    [Abstract] [Full Text] [Related]

  • 17. Trabecular bone score and bone mineral density in acromegalic osteopathy assessment: a cross-sectional study.
    Sorohan MC, Dusceac R, Sorohan BM, Caragheorgheopol A, Poiana C.
    Arch Osteoporos; 2021 Sep 16; 16(1):134. PubMed ID: 34529148
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.